Danny Houtsma
Impact in
-
- Renal cell carcinoma treatment
- Advanced Breast Cancer Therapies
-
- Cancer Treatment and Pharmacology
Papers in
-
- Advanced Breast Cancer Therapies 4
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 1
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Henk‐Jan Guchelaar (6 shared papers)Hans Gelderblom (7 shared papers)Frederiek van den Bos (5 shared papers)Tom van der Hulle (1 shared paper)Johanneke E. A. Portielje (3 shared papers)Loes E. Visser (2 shared papers)Rolf H. H. Groenwold (1 shared paper)J. Zwaveling (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Geriatric Oncology (2 papers)Annals of Oncology (2 papers)ESMO Open (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Danny Houtsma
18 papers receiving 107 citations
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 35
- Oncology 29
- Cancer Research 15
- Pharmacology 8
- Critical Care and Intensive Care Medicine 3
Countries citing papers authored by Danny Houtsma
This map shows the geographic impact of Danny Houtsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Houtsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Houtsma more than expected).
Fields of papers citing papers by Danny Houtsma
This network shows the impact of papers produced by Danny Houtsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Houtsma. The network helps show where Danny Houtsma may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Houtsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 20 | |
| 2 | 2021 | 17 | |
| 3 | 2009 | 14 | |
| 4 | 2022 | 12 | |
| 5 | 2012 | 11 | |
| 6 | 2022 | 6 | |
| 7 | 2024 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 3 | |
| 12 | Variable workup calls for guideline development for type 2A hereditary haemochromatosis. | 2018 | 2 |
| 13 | 2025 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2021 | 0 |
About Danny Houtsma
Danny Houtsma is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Economics and Econometrics and Cancer Research, having authored 20 papers that have together received 107 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), Estrogen and related hormone effects (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renal cell carcinoma treatment (2 papers), Economic and Financial Impacts of Cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (35 citations), Oncology (29 citations), Cancer Research (15 citations), Pharmacology (8 citations) and Critical Care and Intensive Care Medicine (3 citations). Danny Houtsma has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Henk‐Jan Guchelaar, Hans Gelderblom, Frederiek van den Bos, Tom van der Hulle, Johanneke E. A. Portielje, Loes E. Visser, Rolf H. H. Groenwold, J. Zwaveling, Caroline Seynaeve and Barbara C. Van Munster. Their work appears in journals such as Journal of Clinical Oncology, Journal of Geriatric Oncology, Annals of Oncology, ESMO Open and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.